Health authorities in both countries issue warnings as imported cases and local transmissions increase
Australia and New Zealand are witnessing a rise in measles cases this year, prompting public-health agencies to issue alerts and urge vaccination.
In Australia, 59 cases had been confirmed by April, surpassing the total for 2024, and the outbreak has expanded since then.
Western Australia alone reported more than 50 infections and multiple exposure sites across regions including Perth and the South West.
In New Zealand, the national risk has been declared “escalating” by the Ministry of Health, with cases recently identified in regions including Northland, Auckland, Manawatū and Nelson.
Among the exposure sites listed are transport hubs and communal venues, underlining the risk of onward spread.
Health officials attribute the resurgence in part to gaps in immunity and growing global outbreaks of measles.
In Australia, endemic measles was declared eliminated in 2014, but falling vaccination coverage—now estimated at around 92 % among young children—leaves the population vulnerable to imported cases.
One Australian outbreak was linked to a returning traveller who visited multiple public venues while infectious.
The measles, mumps and rubella (MMR)
vaccine remains the best protection.
Authorities in both countries emphasise that two doses confer around 99 % immunity.
Travellers to and from outbreak-affected countries are advised to check their immunisation status, isolate if symptomatic and contact medical services promptly.
Symptoms of measles typically begin with a high fever, cough, runny nose and red eyes, followed after a few days by a distinctive rash.
Because the virus is highly contagious and can linger in the air for up to 30 minutes after an infected person has left, authorities are encouraging heightened vigilance at hospitals, airports and other public locations.
Given the current trajectory of cases and the international spread of the virus, public-health experts are urging Australia and New Zealand to reinforce immunisation programmes, ensure rapid case detection and maintain rigorous monitoring of exposure locations.